“Expired drugs need a dead end, not a detour back to patients.”
“Expired medicines in India should be safely destroyed through approved systems, and strong oversight is important to prevent unlawful resale or re-entry into supply chains.”
Indian law prohibits sale, stocking, exhibition for sale, or distribution of drugs after their expiry period. Official waste-management guidance provides for returning expired medicines to manufacturers or suppliers and for authorized destruction, including incineration in specified circumstances. Recordkeeping and regulatory enforcement are part of the framework.
The post’s 1.5%–2% expiry figure is presented as an estimate but lacks a cited, authoritative nationwide measurement. Its discussion of illegal re-entry is appropriately conditional, but it should not be read as evidence that this is widespread or routinely occurring.
The unsupported precision of the expiry estimate and the lack of prevalence data on diversion do not change the main takeaway: expired medicines require controlled disposal and enforcement.
Why Clear says this
The central message matches India’s legal and public-health framework. The cited risk is conditional rather than a claim of proven, large-scale diversion, so the missing scale data is a limitation rather than material distortion.
Evidence
- India’s Drugs and Cosmetics Act empowers rules that prohibit sale, stocking, exhibition for sale, or distribution after a drug’s expiry date.
- Government guidance states that expired or discarded medicines should be returned to manufacturers or suppliers or disposed of through authorized treatment such as incineration, depending on the waste category.
- Government materials require safe storage and disposal precautions and disposal records for rejected drugs.
- A reliable nationwide official estimate confirming that exactly 1.5%–2% of all medicines expire before use was not identified.